It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
(visit the link for the full news article)
Dendreon Inc.’s $93,000 price tag for its Provenge prostate cancer treatment must be covered under the rules of the U.S. Medicare health plan,
the government agency that determines which treatments will be reimbursed, is required by the Social Security Act to pay for all cancer drugs approved by U.S. regulators
The medicine helped patients live about 4.1 months longer than those given a placebo, according to tests used to gain approval.
I wonder....wouldn't it be less expensive to simply remove the prostate?
Originally posted by ZeroKnowledge
reply to post by Aggie Man
I wonder....wouldn't it be less expensive to simply remove the prostate?
Once cancer is malignant it is usually found only when it "sent" cancer cells to other tissues in other organs. Since cancer is good description of cell going crazy, sometimes removal of primary source of cancer causes those secondary locations to grow much more rapidly.
Of course if you suggest to remove prostate at birth it would eliminate prostate cancer. At a certain cost i am not sure humanity will be able to pay.
Originally posted by dolphinfan
When does it stop? If the drug is shown to lengthen life a week - is that too small to reimburse? How about a day? How do you determine when denying the reimbursement is harming the poor?